PORTAGE BIOTECH INC (PRTG) Stock Analyst Ratings
NASDAQ:PRTG - Nasdaq - VGG7185A1369 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to PRTG. The Buy consensus is the weighted average rating of the current analysts ratings.
PRTG was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about PRTG.
In the previous month the buy percentage consensus was at a similar level.
PRTG was analyzed by 6 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-08 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2023-11-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-09-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-31 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-01 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2022-12-01 | HC Wainwright & Co. | Maintains | Buy |
| 2022-11-30 | Oppenheimer | Maintains | Outperform |
| 2022-09-20 | HC Wainwright & Co. | Maintains | Buy |
| 2022-03-07 | HC Wainwright & Co. | Initiate | Buy |
| 2021-09-21 | Oppenheimer | Initiate | Outperform |
| 2021-09-02 | B. Riley Securities | Initiate | Buy |
| 2021-08-19 | Cantor Fitzgerald | Initiate | Overweight |